Insulet Corporation (PODD)
USD 243.6
(-5.14%)
USD 243.6
(-5.14%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.15 Billion USD | 43.98% |
| 2022 | 805.6 Million USD | 7.11% |
| 2021 | 752.1 Million USD | 29.16% |
| 2020 | 582.3 Million USD | 21.24% |
| 2019 | 480.3 Million USD | 29.75% |
| 2018 | 370.16 Million USD | 33.55% |
| 2017 | 277.16 Million USD | 31.31% |
| 2016 | 211.08 Million USD | 58.39% |
| 2015 | 133.27 Million USD | -6.99% |
| 2014 | 143.28 Million USD | 27.48% |
| 2013 | 112.4 Million USD | 21.73% |
| 2012 | 92.33 Million USD | 38.41% |
| 2011 | 66.71 Million USD | 52.57% |
| 2010 | 43.72 Million USD | 138.98% |
| 2009 | 18.29 Million USD | 499.15% |
| 2008 | -4.58 Million USD | 62.92% |
| 2007 | -12.36 Million USD | -3.03% |
| 2006 | -11.99 Million USD | -710.61% |
| 2005 | -1.48 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 309.9 Million USD | -14.2% |
| 2024 Q2 | 334.2 Million USD | 7.84% |
| 2023 FY | 1.15 Billion USD | 43.98% |
| 2023 Q4 | 361.2 Million USD | 23.15% |
| 2023 Q3 | 293.3 Million USD | 10.72% |
| 2023 Q1 | 240.5 Million USD | 10.68% |
| 2023 Q2 | 264.9 Million USD | 10.15% |
| 2022 Q1 | 209.7 Million USD | -1.64% |
| 2022 Q2 | 190.3 Million USD | -9.25% |
| 2022 Q3 | 188.3 Million USD | -1.05% |
| 2022 Q4 | 217.3 Million USD | 15.4% |
| 2022 FY | 805.6 Million USD | 7.11% |
| 2021 Q2 | 182.7 Million USD | 9.07% |
| 2021 FY | 752.1 Million USD | 29.16% |
| 2021 Q4 | 213.2 Million USD | 12.98% |
| 2021 Q1 | 167.5 Million USD | 3.97% |
| 2021 Q3 | 188.7 Million USD | 3.28% |
| 2020 Q3 | 151.8 Million USD | 6.53% |
| 2020 Q2 | 142.5 Million USD | 12.29% |
| 2020 Q1 | 126.9 Million USD | -5.37% |
| 2020 FY | 582.3 Million USD | 21.24% |
| 2020 Q4 | 161.1 Million USD | 6.13% |
| 2019 FY | 480.3 Million USD | 29.75% |
| 2019 Q1 | 106.69 Million USD | -3.28% |
| 2019 Q2 | 116.41 Million USD | 9.11% |
| 2019 Q3 | 123.08 Million USD | 5.72% |
| 2019 Q4 | 134.1 Million USD | 8.95% |
| 2018 Q1 | 75.81 Million USD | -4.64% |
| 2018 Q2 | 82.07 Million USD | 8.25% |
| 2018 Q3 | 101.96 Million USD | 24.24% |
| 2018 FY | 370.16 Million USD | 33.55% |
| 2018 Q4 | 110.31 Million USD | 8.18% |
| 2017 Q1 | 59.39 Million USD | -2.53% |
| 2017 FY | 277.16 Million USD | 31.31% |
| 2017 Q4 | 79.5 Million USD | 7.99% |
| 2017 Q3 | 73.62 Million USD | 13.9% |
| 2017 Q2 | 64.63 Million USD | 8.82% |
| 2016 Q2 | 50.45 Million USD | 14.54% |
| 2016 Q1 | 44.05 Million USD | -2.8% |
| 2016 Q4 | 60.93 Million USD | 9.52% |
| 2016 FY | 211.08 Million USD | 58.39% |
| 2016 Q3 | 55.64 Million USD | 10.27% |
| 2015 Q3 | 35.65 Million USD | 3.71% |
| 2015 Q1 | 32.8 Million USD | -10.54% |
| 2015 FY | 133.27 Million USD | -6.99% |
| 2015 Q4 | 45.32 Million USD | 27.12% |
| 2015 Q2 | 34.37 Million USD | 4.78% |
| 2014 FY | 143.28 Million USD | 27.48% |
| 2014 Q4 | 36.67 Million USD | -3.6% |
| 2014 Q1 | 32.8 Million USD | -0.64% |
| 2014 Q2 | 35.76 Million USD | 9.01% |
| 2014 Q3 | 38.04 Million USD | 6.37% |
| 2013 Q2 | 26.83 Million USD | 6.67% |
| 2013 FY | 112.4 Million USD | 21.73% |
| 2013 Q4 | 33.01 Million USD | 20.53% |
| 2013 Q3 | 27.39 Million USD | 2.09% |
| 2013 Q1 | 25.15 Million USD | -0.65% |
| 2012 Q4 | 25.31 Million USD | 3.81% |
| 2012 Q1 | 20.29 Million USD | 1.08% |
| 2012 Q3 | 24.39 Million USD | 9.22% |
| 2012 Q2 | 22.33 Million USD | 10.03% |
| 2012 FY | 92.33 Million USD | 38.41% |
| 2011 Q2 | 14.53 Million USD | 7.43% |
| 2011 Q4 | 20.08 Million USD | 8.18% |
| 2011 Q3 | 18.56 Million USD | 27.67% |
| 2011 Q1 | 13.53 Million USD | -2.12% |
| 2011 FY | 66.71 Million USD | 52.57% |
| 2010 Q1 | 8.38 Million USD | 14.33% |
| 2010 Q3 | 11.62 Million USD | 17.63% |
| 2010 Q2 | 9.88 Million USD | 17.9% |
| 2010 Q4 | 13.82 Million USD | 18.89% |
| 2010 FY | 43.72 Million USD | 138.98% |
| 2009 Q4 | 7.33 Million USD | 26.47% |
| 2009 FY | 18.29 Million USD | 499.15% |
| 2009 Q3 | 5.79 Million USD | 82.99% |
| 2009 Q2 | 3.16 Million USD | 58.85% |
| 2009 Q1 | 1.99 Million USD | 66.53% |
| 2008 Q4 | 1.19 Million USD | 1477.01% |
| 2008 FY | -4.58 Million USD | 62.92% |
| 2008 Q1 | -3.32 Million USD | -43.53% |
| 2008 Q2 | -2.36 Million USD | 28.82% |
| 2008 Q3 | -87 Thousand USD | 96.33% |
| 2007 Q1 | -2.56 Million USD | -11.43% |
| 2007 Q4 | -2.31 Million USD | 38.87% |
| 2007 FY | -12.36 Million USD | -3.03% |
| 2007 Q3 | -3.79 Million USD | -2.85% |
| 2007 Q2 | -3.68 Million USD | -43.8% |
| 2006 FY | -11.99 Million USD | -710.61% |
| 2006 Q2 | 674 Thousand USD | 0.0% |
| 2006 Q1 | 674 Thousand USD | 0.0% |
| 2006 Q3 | -3.23 Million USD | -579.53% |
| 2006 Q4 | -2.3 Million USD | 28.81% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | -1.48 Million USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -45386.275% |
| BrainsWay Ltd. | 23.09 Million USD | -4923.169% |
| Cerus Corporation | 86.4 Million USD | -1242.477% |
| Envoy Medical, Inc. | -473 Thousand USD | 245321.987% |
| electroCore, Inc. | 13.22 Million USD | -8669.847% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -1901375.41% |
| IceCure Medical Ltd | 1.3 Million USD | -89123.077% |
| Inogen, Inc. | 126.69 Million USD | -815.477% |
| OrthoPediatrics Corp. | 111.25 Million USD | -942.579% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 19271.901% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 2450454.91% |
| MaxCyte, Inc. | 36.54 Million USD | -3073.808% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -253975.971% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1363525.676% |
| Orthofix Medical Inc. | 486.27 Million USD | -138.529% |
| PAVmed Inc | -3.96 Million USD | 29331.351% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 21246.764% |
| RxSight, Inc. | 53.76 Million USD | -2057.351% |
| Sight Sciences, Inc. | 69.17 Million USD | -1576.762% |
| SI-BONE, Inc. | 109.42 Million USD | -960.044% |
| TELA Bio, Inc. | 40.11 Million USD | -2791.653% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | -663.409% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -13923.697% |
| Acutus Medical, Inc. | -3.13 Million USD | 37074.817% |
| Talis Biomedical Corporation | 371 Thousand USD | -312541.509% |
| Spectral AI, Inc. | 7.88 Million USD | -14619.543% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 17695.57% |
| CVRx, Inc. | 33.03 Million USD | -3410.699% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -156743.708% |
| Bioventus Inc. | 328.19 Million USD | -253.42% |
| Venus Concept Inc. | 52.16 Million USD | -2123.436% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -7192.217% |
| LivaNova PLC | 771.25 Million USD | -50.392% |
| 908 Devices Inc. | 25.32 Million USD | -4480.602% |
| Alphatec Holdings, Inc. | 310.2 Million USD | -273.916% |
| Nemaura Medical Inc. | -1.47 Million USD | 78663.146% |
| NeuroPace, Inc. | 48.12 Million USD | -2310.332% |
| LENSAR, Inc. | 21.1 Million USD | -5395.333% |
| Apyx Medical Corporation | 14.12 Million USD | -8113.426% |
| Cutera, Inc. | 41.49 Million USD | -2695.344% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -6182.975% |
| BioSig Technologies, Inc. | 18 Thousand USD | -6443788.889% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -1025.155% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -8419.906% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | -30.562% |
| Axonics, Inc. | 274.55 Million USD | -322.467% |
| Outset Medical, Inc. | 29 Million USD | -3899.655% |
| IRIDEX Corporation | 21.8 Million USD | -5218.934% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -1532.535% |
| IRadimed Corporation | 50.15 Million USD | -2212.48% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -404046.341% |
| INVO Bioscience, Inc. | 1.08 Million USD | -106691.218% |
| Telesis Bio, Inc. | 16.95 Million USD | -6743.068% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -928.435% |
| Varex Imaging Corporation | 256.9 Million USD | -351.499% |
| Quipt Home Medical Corp. | 163.84 Million USD | -607.925% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 285789.655% |
| Pulmonx Corporation | 50.75 Million USD | -2185.427% |
| Dynatronics Corporation | 7.63 Million USD | -15091.923% |
| Modular Medical, Inc. | -768 Thousand USD | 151128.646% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -20806.633% |
| Semler Scientific, Inc. | 61.2 Million USD | -1795.261% |
| InMode Ltd. | 411.34 Million USD | -181.981% |
| Bruker Corporation | 1.51 Billion USD | 23.53% |
| Cytosorbents Corporation | 22.39 Million USD | -5079.97% |
| DexCom, Inc. | 2.28 Billion USD | 49.325% |
| Align Technology, Inc. | 2.71 Billion USD | 57.337% |
| Viveve Medical, Inc. | 620 Thousand USD | -186980.645% |
| ZimVie Inc. | 290.38 Million USD | -299.438% |
| Movano Inc. | -158 Thousand USD | 734213.924% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -959.986% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1363525.676% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | -215.456% |
| Profound Medical Corp. | 4.51 Million USD | -25595.494% |
| enVVeno Medical Corporation | -546 Thousand USD | 212535.897% |
| Surmodics, Inc. | 93.05 Million USD | -1146.507% |
| iCAD, Inc. | 14.53 Million USD | -7879.499% |
| Nuwellis, Inc. | 4.98 Million USD | -23177.142% |
| Biotricity, Inc. | 8.35 Million USD | -13780.577% |
| iRhythm Technologies, Inc. | 331.8 Million USD | -249.572% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 323140.631% |
| InspireMD, Inc. | 1.8 Million USD | -64089.264% |
| PAVmed Inc. | -3.96 Million USD | 29331.351% |
| BIOLASE, Inc. | 16.72 Million USD | -6835.541% |
| Beyond Air, Inc. | -1.3 Million USD | 88845.218% |
| FONAR Corporation | 45.14 Million USD | -2469.559% |
| AxoGen, Inc. | 127.87 Million USD | -807.065% |
| Vivani Medical, Inc. | -357 Thousand USD | 325001.961% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | -494.415% |
| Inari Medical, Inc. | 434.56 Million USD | -166.911% |
| UFP Technologies, Inc. | 112.22 Million USD | -933.549% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -9265017.022% |
| Tenon Medical, Inc. | 1.24 Million USD | -93364.948% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 1432075.309% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -44051.53% |
| AdaptHealth Corp. | 479.56 Million USD | -141.866% |
| Sintx Technologies, Inc. | 1.84 Million USD | -62835.431% |
| NanoVibronix, Inc. | 1.53 Million USD | -75365.192% |
| Quanterix Corporation | 70.64 Million USD | -1541.848% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 285789.655% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -8149.644% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -2097.613% |
| TransMedics Group, Inc. | 154.09 Million USD | -652.727% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -25947.608% |
| NeuroMetrix, Inc. | 3.94 Million USD | -29283.801% |
| Hyperfine, Inc. | 4.75 Million USD | -24283.015% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -984.252% |
| Biomerica, Inc. | 611 Thousand USD | -189736.334% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -2682.377% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 148623.282% |
| Silk Road Medical, Inc | 127.08 Million USD | -812.689% |